These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22187312)

  • 1. Effect of glycosylation on biodistribution of radiolabeled glucagon-like peptide 1.
    Watanabe A; Nishijima K; Zhao S; Tanaka Y; Itoh T; Takemoto H; Tamaki N; Kuge Y
    Ann Nucl Med; 2012 Feb; 26(2):184-91. PubMed ID: 22187312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoenzymatic synthesis of glycosylated glucagon-like peptide 1: effect of glycosylation on proteolytic resistance and in vivo blood glucose-lowering activity.
    Ueda T; Tomita K; Notsu Y; Ito T; Fumoto M; Takakura T; Nagatome H; Takimoto A; Mihara S; Togame H; Kawamoto K; Iwasaki T; Asakura K; Oshima T; Hanasaki K; Nishimura S; Kondo H
    J Am Chem Soc; 2009 May; 131(17):6237-45. PubMed ID: 19361194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas.
    Steyn LV; Ananthakrishnan K; Anderson MJ; Patek R; Kelly A; Vagner J; Lynch RM; Limesand SW
    Mol Imaging Biol; 2015 Aug; 17(4):461-70. PubMed ID: 25604385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.
    Gotthardt M; Fischer M; Naeher I; Holz JB; Jungclas H; Fritsch HW; Béhé M; Göke B; Joseph K; Behr TM
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):597-606. PubMed ID: 11976797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [¹²⁵I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta.
    Kuc RE; Maguire JJ; Siew K; Patel S; Derksen DR; Margaret Jackson V; O'Shaughnessey KM; Davenport AP
    Life Sci; 2014 May; 102(2):134-8. PubMed ID: 24641952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera.
    Hassan M; Eskilsson A; Nilsson C; Jonsson C; Jacobsson H; Refai E; Larsson S; Efendic S
    Nucl Med Biol; 1999 May; 26(4):413-20. PubMed ID: 10382845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity.
    Seo D; Faintuch BL; Aparecida de Oliveira E; Faintuch J
    Nucl Med Biol; 2017 Jun; 49():57-64. PubMed ID: 28365524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
    Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
    J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.
    Gotthardt M; Lalyko G; van Eerd-Vismale J; Keil B; Schurrat T; Hower M; Laverman P; Behr TM; Boerman OC; Göke B; Béhé M
    Regul Pept; 2006 Dec; 137(3):162-7. PubMed ID: 16930741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast renal trapping of porcine luteinizing hormone (pLH) shown by 123I-scintigraphic imaging in rats explains its short circulatory half-life.
    Klett D; Bernard S; Lecompte F; Leroux H; Magallon T; Locatelli A; Lepape A; Combarnous Y
    Reprod Biol Endocrinol; 2003 Oct; 1():64. PubMed ID: 14585104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro characterization of Glucagon-Like Peptide-1 derivatives for pancreatic beta cell imaging by SPECT.
    Behnam Azad B; Rota VA; Breadner D; Dhanvantari S; Luyt LG
    Bioorg Med Chem; 2010 Feb; 18(3):1265-72. PubMed ID: 20056547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future.
    Hubalewska-Dydejczyk A; Sowa-Staszczak A; Tomaszuk M; Stefańska A
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):152-60. PubMed ID: 25719487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glycosylated exendin-4 analogue with prolonged blood glucose-lowering activity through glycosylation scanning substitution.
    Ueda T; Ito T; Tomita K; Togame H; Fumoto M; Asakura K; Oshima T; Nishimura S; Hanasaki K
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4631-4. PubMed ID: 20576431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-Directed Glycosylation of Peptide/Protein with Homogeneous O-Linked Eukaryotic N-Glycans.
    Wu Z; Jiang K; Zhu H; Ma C; Yu Z; Li L; Guan W; Liu Y; Zhu H; Chen Y; Li S; Li J; Cheng J; Zhang L; Wang PG
    Bioconjug Chem; 2016 Sep; 27(9):1972-5. PubMed ID: 27529638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.
    Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
    Rocca AS; LaGreca J; Kalitsky J; Brubaker PL
    Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1.
    Patterson JT; Ottaway N; Gelfanov VM; Smiley DL; Perez-Tilve D; Pfluger PT; Tschöp MH; Dimarchi RD
    ACS Chem Biol; 2011 Feb; 6(2):135-45. PubMed ID: 20939591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
    Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.